Seung Tae Kim

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Network Analysis

Epidermal Growth Factor Receptor

Neoadjuvant Chemotherapy

Metastatic Breast Cancer

Top Venues

Cancer discovery

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Minae An, Arnav Mehta, Byung-Hoon Min, You Jeong Heo, Samuel J Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J Park, Matthew R Strickland, Woong-Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Samuel J Klempner, Jeeyun Lee
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer. Cancer discovery 14 (5) (2024)
Sung Hee Lim, Min Jung Kim, Jeeyun Lee, Ho Yeong Lim, Won Ki Kang, Seung Tae Kim
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer. Cancers 16 (17) (2024)
Minae An, Arnav Mehta, Byung-Hoon Min, You Jeong Heo, Samuel J Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J Park, Matthew R Strickland, Woong-Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Samuel J Klempner, Jeeyun Lee
Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric cancer. Cancer discovery (2024)
Minae An, Arnav Mehta, Byung-Hoon Min, You Jeong Heo, Samuel J Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J Park, Matthew R Strickland, Woong-Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Samuel J Klempner, Jeeyun Lee
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer. Cancer discovery 14 (5) (2024)
Minae An, Arnav Mehta, Byung-Hoon Min, You Jeong Heo, Samuel J Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J Park, Matthew R Strickland, Woong-Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Samuel J Klempner, Jeeyun Lee
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer. Cancer discovery 14 (5) (2024)
Minae An, Arnav Mehta, Byung-Hoon Min, You Jeong Heo, Samuel J Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee, Jeonghyeon Moon, Ryan J Park, Matthew R Strickland, Woong-Yang Park, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim, Samuel J Klempner, Jeeyun Lee
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer. Cancer discovery 14 (5) (2024)
Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M Blum, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ho Yeong Lim, Samuel J Klempner, Jeeyun Lee
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer. Science advances 9 (47) (2023)
Jaeyun Jung, Seung Tae Kim, Jihoon Ko, Jung Yong Hong, Joon Oh Park, Sang-Yun Ha, Jeeyun Lee
Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis. JCO precision oncology 7 (2023)
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D Galsky, Erika Paige Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun-Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J Monk, Danny Nguyen, Do Youn Oh, Alicia F C Okines, David M O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cedric Van Marcke, Evan Y Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas Eldridge Stinchcombe, Tanios S Bekaii-Saab
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ryul Kim, Minae An, Hyuk Lee, Arnav Mehta, You Jeong Heo, Kyoung-Mee Kim, Song-Yi Lee, Jeonghyeon Moon, Seung Tae Kim, Byung-Hoon Min, Tae Jun Kim, Sun Young Rha, Won Ki Kang, Woong-Yang Park, Samuel J Klempner, Jeeyun Lee
Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer. Cancer discovery 12 (4) (2022)
Seung Tae Kim, Sun Young Kim, Jeeyun Lee, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Tae Won Kim, Yong Sang Hong, Seok Byung Lim, Ji Yeon Baek, Jae Hwan Oh, Joong Bae Ahn, Sang Joon Shin, Sae-Won Han, Seong Geun Kim, Seok Yun Kang, Sun Jin Sym, Dae Young Zang, Yeul Hong Kim, In Sil Choi, Jung Hun Kang, Min-Ji Kim, Young Suk Park
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Seung Tae Kim, Simon A Smith, Peter G S Mortimer, Arsene-Bienvenu Loembé, Heejin Cho, Kyoung-Mee Kim, Claire Smith, Sophie Willis, Itziar Irurzun-Arana, Alienor Berges, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Iwanka Kozarewa, Andrew J Pierce, Emma Dean, Jeeyun Lee
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Su Jin Lee, Jung Yong Hong, Kyung Kim, Kyoung-Mee Kim, So Young Kang, Taeyang Lee, Seung Tae Kim, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Joon Oh Park
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers. Journal of oncology 2020 (2020)
Seonggyu Byeon, Jung Yong Hong, Jeeyun Lee, Do-Hyun Nam, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Seung Tae Kim
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study. Targeted oncology 15 (2) (2020)